Selumetinib-impurities | Pharmaffiliates

Selumetinib

Selumetinib is a drug. It is under investigation for the treatment of Carcinoma, Thymic, Non-Small Cell Lung Cancer.Reference standards of Selumetinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Selumetinib - API Standards 
    [catalogue_number] => PA 46 42000
    [category_ids] => ,80,71,81,78,70,82,
    [chemical_name] => 
    [weight] => 457.68
    [form] => C17H15BrClFN4O3
    [cas] => 606143-52-6
    [pslug] => 606143-52-6-selumetinib-api-pa4642000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 46 42000

Selumetinib - API Standards


  • Catalogue No.:PA 46 42000

  • CAS :

    606143-52-6

  • Molecular Formula : C17H15BrClFN4O3

  • Molecular Weight : 457.68